Tang, Yong, and Yibin Kang. (2022) 2022. “Microbial Metabolite As Icebreaker for Immunotherapy”. Cell Metab 34 (4): 506-7. doi:10.1016/j.cmet.2022.03.003.

Spadazzi, Chiara, Laura Mercatali, Mark Esposito, Yong Wei, Chiara Liverani, Alessandro De Vita, Giacomo Miserocchi, et al. (2021) 2021. “Trefoil Factor-1 Upregulation in Estrogen-Receptor Positive Breast Cancer Correlates With an Increased Risk of Bone Metastasis”. Bone 144: 115775. doi:10.1016/j.bone.2020.115775.

Meng, Jingjing, Yi-Zhou Jiang, Shen Zhao, Yuwei Tao, Tengjiang Zhang, Xuxiang Wang, Yuan Zhang, et al. (2022) 2022. “Tumor-Derived Jagged1 Promotes Cancer Progression through Immune Evasion”. Cell Rep 38 (10): 110492. doi:10.1016/j.celrep.2022.110492.

Shen, Minhong, Yong Wei, Hahn Kim, Liling Wan, Yi-Zhou Jiang, Xiang Hang, Michael Raba, et al. (2022) 2022. “Small-Molecule Inhibitors That Disrupt the MTDH-SND1 Complex Suppress Breast Cancer Progression and Metastasis”. Nat Cancer 3 (1): 43-59. doi:10.1038/s43018-021-00279-5.

Pérez-Núñez, Iván, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández-Prat, et al. (2022) 2022. “LCOR Mediates Interferon-Independent Tumor Immunogenicity and Responsiveness to Immune-Checkpoint Blockade in Triple-Negative Breast Cancer”. Nat Cancer 3 (3): 355-70. doi:10.1038/s43018-022-00339-4.

Shen, Minhong, Heath Smith, Yong Wei, Yi-Zhou Jiang, Sheng Zhao, Nicole Wang, Michelle Rowicki, et al. (2022) 2022. “Pharmacological Disruption of the MTDH-SND1 Complex Enhances Tumor Antigen Presentation and Synergizes With Anti-PD-1 Therapy in Metastatic Breast Cancer”. Nat Cancer 3 (1): 60-74. doi:10.1038/s43018-021-00280-y.

Kumar, Sushil, Ajeya Nandi, Snahlata Singh, Rohan Regulapati, Ning Li, John Tobias, Christian Siebel, et al. (2021) 2021. “Dll1 Quiescent Tumor Stem Cells Drive Chemoresistance in Breast Cancer through NF-κB Survival Pathway”. Nat Commun 12 (1): 432. doi:10.1038/s41467-020-20664-5.

Lee, Eunmi, and Yibin Kang. (2021) 2021. “Lineage Tracing Reveals Metastatic Dynamics”. Cancer Cell 39 (8): 1050-52. doi:10.1016/j.ccell.2021.06.005.

Chen, Fenfang, Yujiao Han, and Yibin Kang. (2021) 2021. “Bone Marrow Niches in the Regulation of Bone Metastasis”. Br J Cancer 124 (12): 1912-20. doi:10.1038/s41416-021-01329-6.

Kang, Yibin, and Charlotte Kuperwasser. (2021) 2021. “Evolving Barcodes Shed Light into Evolving Metastases”. Dev Cell 56 (8): 1077-79. doi:10.1016/j.devcel.2021.03.029.

Fang, Cao, and Yibin Kang. (2021) 2021. “E-Cadherin: Context-Dependent Functions of a Quintessential Epithelial Marker in Metastasis”. Cancer Res 81 (23): 5800-5802. doi:10.1158/0008-5472.CAN-21-3302.

Pham, Kien, Do Huynh, Le Le, Daniel Delitto, Lei Yang, Jing Huang, Yibin Kang, et al. (2020) 2020. “E-Cigarette Promotes Breast Carcinoma Progression and Lung Metastasis: Macrophage-Tumor Cells Crosstalk and the Role of CCL5 and VCAM-1”. Cancer Lett 491: 132-45. doi:10.1016/j.canlet.2020.08.010.

Fang, Cao, and Yibin Kang. (2022) 2022. “Cellular Plasticity in Bone Metastasis”. Bone 158: 115693. doi:10.1016/j.bone.2020.115693.

Fan, Huijuan, Xuxiang Wang, Wenyang Li, Minhong Shen, Yong Wei, Hanqiu Zheng, and Yibin Kang. (2020) 2020. “ASB13 Inhibits Breast Cancer Metastasis through Promoting SNAI2 Degradation and Relieving Its Transcriptional Repression of YAP”. Genes Dev 34 (19-20): 1359-72. doi:10.1101/gad.339796.120.

Li, Wenyang, Minhong Shen, Yi-Zhou Jiang, Ruina Zhang, Hanqiu Zheng, Yong Wei, Zhi-Ming Shao, and Yibin Kang. (2020) 2020. “Deubiquitinase USP20 Promotes Breast Cancer Metastasis by Stabilizing SNAI2”. Genes Dev 34 (19-20): 1310-15. doi:10.1101/gad.339804.120.

Ghergurovich, Jonathan, Mark Esposito, Zihong Chen, Joshua Wang, Vrushank Bhatt, Taijin Lan, Eileen White, Yibin Kang, Jessie Yanxiang Guo, and Joshua Rabinowitz. (2020) 2020. “Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis”. Cancer Res 80 (18): 3820-29. doi:10.1158/0008-5472.CAN-19-2486.

Vrla, Geoffrey, Mark Esposito, Chen Zhang, Yibin Kang, Mohammad Seyedsayamdost, and Zemer Gitai. (2020) 2020. “Cytotoxic Alkyl-Quinolones Mediate Surface-Induced Virulence in Pseudomonas Aeruginosa”. PLoS Pathog 16 (9): e1008867. doi:10.1371/journal.ppat.1008867.

Hoshino, Ayuko, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan Hernandez, Constantinos Zambirinis, et al. (2020) 2020. “Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers”. Cell 182 (4): 1044-1061.e18. doi:10.1016/j.cell.2020.07.009.

Aiello-Couzo, Nicole, and Yibin Kang. (2020) 2020. “A Bridge Between Melanoma Cell States”. Nat Cell Biol 22 (8): 913-14. doi:10.1038/s41556-020-0556-2.

Yang, Jing, Parker Antin, Geert Berx, Cédric Blanpain, Thomas Brabletz, Marianne Bronner, Kyra Campbell, et al. (2020) 2020. “Guidelines and Definitions for Research on Epithelial-Mesenchymal Transition”. Nat Rev Mol Cell Biol 21 (6): 341-52. doi:10.1038/s41580-020-0237-9.

Shen, Minhong, and Yibin Kang. (2019) 2019. “Role Reversal: A Pro-Metastatic Function of E-Cadherin”. Dev Cell 51 (4): 417-19. doi:10.1016/j.devcel.2019.10.028.

Lu, Wei, and Yibin Kang. (2019) 2019. “Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis”. Dev Cell 49 (3): 361-74. doi:10.1016/j.devcel.2019.04.010.

Esposito, Mark, Shridar Ganesan, and Yibin Kang. (2021) 2021. “Emerging Strategies for Treating Metastasis”. Nat Cancer 2 (3): 258-70. doi:10.1038/s43018-021-00181-0.

Esposito, Mark, Cao Fang, Katelyn Cook, Nana Park, Yong Wei, Chiara Spadazzi, Dan Bracha, et al. (2021) 2021. “TGF-β-Induced DACT1 Biomolecular Condensates Repress Wnt Signalling to Promote Bone Metastasis”. Nat Cell Biol 23 (3): 257-67. doi:10.1038/s41556-021-00641-w.

Shen, Minhong, Shanshan Xie, Michelle Rowicki, Sven Michel, Yong Wei, Xiang Hang, Liling Wan, et al. (2021) 2021. “Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis”. Cancer Res 81 (4): 1014-25. doi:10.1158/0008-5472.CAN-20-1876.

Peng, Jia, and Yibin Kang. (2017) 2017. “The Bony Side of Endothelial Cells in Prostate Cancer”. Dev Cell 41 (5): 451-52. doi:10.1016/j.devcel.2017.05.015.

Celià-Terrassa, Toni, Daniel Liu, Abrar Choudhury, Xiang Hang, Yong Wei, Jose Zamalloa, Raymundo Alfaro-Aco, et al. (2017) 2017. “Normal and Cancerous Mammary Stem Cells Evade Interferon-Induced Constraint through the MiR-199a-LCOR Axis”. Nat Cell Biol 19 (6): 711-23. doi:10.1038/ncb3533.

Oslund, Rob, Xiaoyang Su, Michael Haugbro, Jung-Min Kee, Mark Esposito, Yael David, Boyuan Wang, et al. (2017) 2017. “Bisphosphoglycerate Mutase Controls Serine Pathway Flux via 3-Phosphoglycerate”. Nat Chem Biol 13 (10): 1081-87. doi:10.1038/nchembio.2453.

Alečković, Maša, Yong Wei, Gary LeRoy, Simone Sidoli, Daniel Liu, Benjamin Garcia, and Yibin Kang. (2017) 2017. “Identification of Nidogen 1 As a Lung Metastasis Protein through Secretome Analysis”. Genes Dev 31 (14): 1439-55. doi:10.1101/gad.301937.117.

Zheng, Hanqiu, Yangjin Bae, Sabine Kasimir-Bauer, Rebecca Tang, Jin Chen, Guangwen Ren, Min Yuan, et al. (2017) 2017. “Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy”. Cancer Cell 32 (6): 731-747.e6. doi:10.1016/j.ccell.2017.11.002.

Chen, Chang-Rung, Yibin Kang, Peter Siegel, and Joan Massagué. (2002) 2002. “E2F4/5/and/p107/As/Smad/Cofactors/Linking/the/TGFbeta/Receptor/to/C-Myc/Repression.”. Cell 110 (1): 19-32.

Ho, Dona, Glen Coburn, Yibin Kang, Bryan Cullen, and Millie Georgiadis. (2002) 2002. “The Crystal Structure and Mutational Analysis of a Novel RNA-Binding Domain Found in the Human Tap Nuclear MRNA Export Factor.”. Proc Natl Acad Sci U S A 99 (4): 1888-93. doi:10.1073/pnas.042698599.

Wiegand, Heather, Glen Coburn, Yan Zeng, Yibin Kang, Hal Bogerd, and Bryan Cullen. (2002) 2002. “Formation of Tap NXT1 Heterodimers Activates Tap-Dependent Nuclear MRNA Export by Enhancing Recruitment to Nuclear Pore Complexes.”. Mol Cell Biol 22 (1): 245-56.

Minn, Andy, Yibin Kang, Inna Serganova, Gaorav Gupta, Dilip Giri, Mikhail Doubrovin, Vladimir Ponomarev, William Gerald, Ronald Blasberg, and Joan Massagué. (2005) 2005. “Distinct Organ-Specific Metastatic Potential of Individual Breast Cancer Cells and Primary Tumors.”. J Clin Invest 115 (1): 44-55. doi:10.1172/JCI22320.

Kang, Yibin, and Joan Massagué. (2004) 2004. “Epithelial-Mesenchymal Transitions: Twist in Development and Metastasis.”. Cell 118 (3): 277-9. doi:10.1016/j.cell.2004.07.011.

Kang, Yibin, Peter Siegel, Weiping Shu, Maria Drobnjak, Sanna Kakonen, Carlos Cordón-Cardo, Theresa Guise, and Joan Massagué. (2003) 2003. “A Multigenic Program Mediating Breast Cancer Metastasis to Bone.”. Cancer Cell 3 (6): 537-49.

Kang, Yibin, Chang-Rung Chen, and Joan Massagué. (2003) 2003. “A Self-Enabling TGFbeta Response Coupled to Stress Signaling: Smad Engages Stress Response Factor ATF3 for Id1 Repression in Epithelial Cells.”. Mol Cell 11 (4): 915-26.

Xu, Lan, Yibin Kang, Seda Cöl, and Joan Massagué. (2002) 2002. “Smad2 Nucleocytoplasmic Shuttling by Nucleoporins CAN Nup214 and Nup153 Feeds TGFbeta Signaling Complexes in the Cytoplasm and Nucleus.”. Mol Cell 10 (2): 271-82.

Li, Feng, Benjamin Tiede, Joan Massagué, and Yibin Kang. (2007) 2007. “Beyond Tumorigenesis: Cancer Stem Cells in Metastasis.”. Cell Res 17 (1): 3-14. doi:10.1038/sj.cr.7310118.

Kang, Yibin. (2006) 2006. “Pro-Metastasis Function of TGFbeta Mediated by the Smad Pathway.”. J Cell Biochem 98 (6): 1380-90. doi:10.1002/jcb.20928.

Kang, Yibin, Wei He, Shaun Tulley, Gaorav Gupta, Inna Serganova, Chang-Rung Chen, Katia Manova-Todorova, Ronald Blasberg, William Gerald, and Joan Massagué. (2005) 2005. “Breast Cancer Bone Metastasis Mediated by the Smad Tumor Suppressor Pathway.”. Proc Natl Acad Sci U S A 102 (39): 13909-14. doi:10.1073/pnas.0506517102.

Kang, Yibin. (2005) 2005. “Functional Genomic Analysis of Cancer Metastasis: Biologic Insights and Clinical Implications.”. Expert Rev Mol Diagn 5 (3): 385-95. doi:10.1586/14737159.5.3.385.

Kang, Yibin. 2009. “Analysis of Cancer Stem Cell Metastasis in Xenograft Animal Models.”. Methods Mol Biol 568: 7-19. doi:10.1007/978-1-59745-280-9_2.

Wei, Yong, Guohong Hu, and Yibin Kang. (2009) 2009. “Metadherin As a Link Between Metastasis and Chemoresistance.”. Cell Cycle 8 (14): 2132-3.

Lu, Xin, and Yibin Kang. (2009) 2009. “Efficient Acquisition of Dual Metastasis Organotropism to Bone and Lung through Stable Spontaneous Fusion Between MDA-MB-231 Variants.”. Proc Natl Acad Sci U S A 106 (23): 9385-90. doi:10.1073/pnas.0900108106.

Korpal, Manav, and Yibin Kang. (2008) 2008. “The Emerging Role of MiR-200 Family of MicroRNAs in Epithelial-Mesenchymal Transition and Cancer Metastasis.”. RNA Biol 5 (3): 115-9.

Hu, Guohong, Robert Chong, Qifeng Yang, Yong Wei, Mario Blanco, Feng Li, Michael Reiss, Jessie Au, Bruce Haffty, and Yibin Kang. (2009) 2009. “MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer.”. Cancer Cell 15 (1): 9-20. doi:10.1016/j.ccr.2008.11.013.

Korpal, Manav, Esther Lee, Guohong Hu, and Yibin Kang. (2008) 2008. “The MiR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-Cadherin Transcriptional Repressors ZEB1 and ZEB2.”. J Biol Chem 283 (22): 14910-4. doi:10.1074/jbc.C800074200.

Zhu, Ji, Xun Jia, Guozhi Xiao, Yibin Kang, Nicola Partridge, and Ling Qin. (2007) 2007. “EGF-Like Ligands Stimulate Osteoclastogenesis by Regulating Expression of Osteoclast Regulatory Factors by Osteoblasts: Implications for Osteolytic Bone Metastases.”. J Biol Chem 282 (37): 26656-64. doi:10.1074/jbc.M705064200.

Lu, Xin, and Yibin Kang. (2007) 2007. “Organotropism of Breast Cancer Metastasis.”. J Mammary Gland Biol Neoplasia 12 (2-3): 153-62. doi:10.1007/s10911-007-9047-3.